Danimer Scientific, Inc. (NYSE:DNMR – Get Rating) – Equities researchers at Jefferies Financial Group lifted their Q3 2022 earnings per share (EPS) estimates for shares of Danimer Scientific in a research report issued to clients and investors on Tuesday, September 6th. Jefferies Financial Group analyst L. Alexander now forecasts that the company will post earnings per share of ($0.19) for the quarter, up from their prior forecast of ($0.20). The consensus estimate for Danimer Scientific's current full-year earnings is ($0.94) per share. Jefferies Financial Group also issued estimates for Danimer Scientific's Q4 2022 earnings at ($0.06) EPS, FY2023 earnings at ($0.50) EPS, FY2024 earnings at ($0.20) EPS, FY2025 earnings at ($0.05) EPS and FY2026 earnings at $0.20 EPS.

Separately, Cowen cut their price objective on Danimer Scientific to $6.00 in a research note on Monday, August 15th.

Danimer Scientific Stock Down 4.2 %

Danimer Scientific (NYSE:DNMR – Get Rating) last posted its quarterly earnings results on Tuesday, August 9th. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.04). Danimer Scientific had a negative return on equity of 19.28% and a negative net margin of 104.97%. The firm had revenue of $12.70 million for the quarter.

Institutional Trading of Danimer Scientific

Institutional investors have recently modified their holdings of the company. Northern Trust Corp boosted its stake in Danimer Scientific by 33.5% in the 4th quarter. Northern Trust Corp now owns 868,043 shares of the company's stock valued at $7,396,000 after buying an additional 217,881 shares in the last quarter. ProShare Advisors LLC acquired a new stake in Danimer Scientific in the 4th quarter valued at $169,000. State Board of Administration of Florida Retirement System acquired a new stake in Danimer Scientific in the 4th quarter valued at $108,000. Swiss National Bank boosted its stake in Danimer Scientific by 13.8% in the 4th quarter. Swiss National Bank now owns 172,000 shares of the company's stock valued at $1,465,000 after buying an additional 20,800 shares in the last quarter. Finally, Raymond James & Associates boosted its stake in Danimer Scientific by 18.4% in the 4th quarter. Raymond James & Associates now owns 55,958 shares of the company's stock valued at $477,000 after buying an additional 8,693 shares in the last quarter. Institutional investors and hedge funds own 44.98% of the company's stock.

Insider Activity at Danimer Scientific

In other Danimer Scientific news, CMO Scott Tuten sold 10,000 shares of the firm's stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $5.08, for a total value of $50,800.00. Following the sale, the chief marketing officer now owns 474,136 shares of the company's stock, valued at approximately $2,408,610.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Stuart W. Pratt sold 75,327 shares of Danimer Scientific stock in a transaction that occurred on Thursday, August 18th. The stock was sold at an average price of $5.25, for a total transaction of $395,466.75. Following the sale, the director now owns 1,519,238 shares of the company's stock, valued at approximately $7,975,999.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CMO Scott Tuten sold 10,000 shares of Danimer Scientific stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $5.08, for a total value of $50,800.00. Following the sale, the chief marketing officer now directly owns 474,136 shares in the company, valued at approximately $2,408,610.88. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 105,327 shares of company stock valued at $534,767. Corporate insiders own 14.60% of the company's stock.

About Danimer Scientific

(Get Rating)

Danimer Scientific, Inc, a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.

Featured Articles

• Get a free copy of the StockNews.com research report on Danimer Scientific (DNMR)
• Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
• Are These Green Energy Companies Right For Your Portfolio?
• When Will the Hangover Finally Be Over for Seagate Technology?
• Does Enphase Energy Have the Juice to Keep Powering Higher?
• The One Hydrogen Fuel Cell Stock To Rule Them All

Receive News & Ratings for Danimer Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danimer Scientific and related companies with MarketBeat.com's FREE daily email newsletter.